<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00037141</url>
  </required_header>
  <id_info>
    <org_study_id>AMS002</org_study_id>
    <nct_id>NCT00037141</nct_id>
  </id_info>
  <brief_title>Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)</brief_title>
  <official_title>Evaluation of the Safety and Tolerability of Transurethral Alcohol Injection for the Treatment of BPH (Enlarged Prostate)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American Medical Systems</source>
  <brief_summary>
    <textblock>
      Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men
      will be enrolled in the study. Qualifying patients will receive one of three possible doses
      of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month,
      3-months, and 6-months following treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date>March 2004</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>150</enrollment>
  <condition>Prostate Disease</condition>
  <condition>BPH</condition>
  <condition>Benign Prostatic Hyperplasia</condition>
  <condition>Benign Prostatic Hypertrophy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dehydrated alcohol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligible patients are 50 to 80-year-old men who have experienced some or all of the
        following urinary symptoms for at least 6 months:

          -  frequent or urgent need to urinate

          -  difficulty starting their urinary stream

          -  interruption of their urinary stream

          -  feeling of incomplete emptying of bladder after urinating

          -  interruption of sleep due to the urge to urinate

        Patients should have tried oral medication for their condition in the past, and be willing
        to discontinue any current BPH medications for a period of time before undergoing study
        treatment. They should be in good general health and have no previous surgery, or other
        procedure(s) intended to reduce prostate size.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2002</study_first_submitted>
  <study_first_submitted_qc>May 16, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2002</study_first_posted>
  <last_update_submitted>October 4, 2007</last_update_submitted>
  <last_update_submitted_qc>October 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2007</last_update_posted>
  <keyword>Prostate</keyword>
  <keyword>BPH</keyword>
  <keyword>Prostatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Prostatic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

